All In Biotech

Free tool

FAERS Monitor: Nucynta Er

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 200533 or its brand name (Nucynta Er, Tapentadol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

33,575

Serious

30,074

90% of reports

Hospitalization

4,531

Death reported

20,764

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death11,645
  • toxicity to various agents9,959
  • overdose5,890
  • drug abuse1,553
  • drug dependence1,073
  • drug ineffective1,039
  • drug withdrawal syndrome neonatal944
  • pain767
  • nausea735
  • accidental overdose721
  • fatigue457
  • headache418
  • dizziness414
  • somnolence409
  • drug interaction404

Reports by year received

View as table
YearReports
20051
20082
200998
2010155
2011350
2012418
2013377
2014364
20151,376
20161,060
20172,490
201821,688
2019848
2020729
2021705
2022593
2023559
2024706
2025546
2026510

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,020,584 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug withdrawal syndrome neonatalSignal94442.639.935,883
toxicity to various agentsSignal9,95939.338.6352,128
overdoseSignal5,89017.617.190,367
accidental overdoseSignal72112.611.77,533
drug abuseSignal1,55311.911.315,251
deathSignal11,6458.68.480,085
drug dependenceSignal1,0734.24.02,617
drug interaction4041.61.490
somnolence4091.31.224
pain7670.80.748
nausea7350.60.5230
dizziness4140.50.5188
drug ineffective1,0390.50.5575
headache4180.40.4350
fatigue4570.40.3516

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.